The circadian clock, metabolism, and inflammation-the holy trinity of inflammatory bowel diseases. [PDF]
Froy O, Weintraub Y.
europepmc +1 more source
Fecal calprotectin in inflammatory bowel diseases: update and perspectives
H. Manceau +3 more
semanticscholar +1 more source
Fatigue in children and adolescents with inflammatory bowel disease: a cross-sectional study [PDF]
Yahui Zuo +4 more
openalex +1 more source
This study identifies the transcription factor ETV1 as a key driver of CD4⁺ T cell‐mediated intestinal inflammation in inflammatory bowel disease (IBD). ETV1 promotes CD4⁺ T cell activation, proliferation, and Th17 differentiation by activating the amino acid transporter SLC7A5, fueling metabolic reprogramming.
Yan Shi +8 more
wiley +1 more source
Pharmacoepigenetic Biomarkers in Inflammatory Bowel Diseases: A Narrative Review. [PDF]
Servian JE +4 more
europepmc +1 more source
Hepatic manifestations of inflammatory bowel diseases
S. Restellini +2 more
semanticscholar +1 more source
Burden of delirium on mortality and healthcare resource utilization in geriatric patients hospitalized for inflammatory bowel disease [PDF]
Mohammad Aldiabat +10 more
openalex +1 more source
Notch2 Directs aTreg Cell Fate toward Immunoregulation or Inflammatory Pyroptosis
Schematic illustration showing that the Notch2 intracellular domain (NICD2) facilitates pyroptosis resistance in activated Tregs through the RREB1/Foxo1 signaling pathway. In addition, Notch2‐mediated pyroptosis resistance in activated Tregs promotes immunoregulatory capacity, thereby attenuating Th2‐driven inflammatory responses in allergic rhinitis ...
Yue‐Long Qiao +10 more
wiley +1 more source
Readmissions in Inflammatory Bowel Diseases: A Five-Year Retrospective Study in a Romanian Emergency County Hospital. [PDF]
Grama P, Zadea V, Ciurea NA, Bataga SM.
europepmc +1 more source
Targeting hyaluronan synthesis enhances the therapeutic effectiveness of biologics in inflammatory bowel disease [PDF]
Peng Xiao +16 more
openalex +1 more source

